The always eagerly-awaited Medicare Advantage Call Letter, this one for 2016, is now available, promising a meager premium increase for plans.
Read More
A survey sponsored by Evolution1's Healthcare Trends Institute focuses on employer health benefit trends.
Read More
A paper from Elsevier explores reasons for the recent uptick in generic drug prices.
Read More
Research in the New England Journal of Medicine looks at whether the most recent guidelines in blood pressure control would lead to cost savings.
Read More
CMS is extending hospital readmission penalties to surgeries. An article in the Journal of the American Medical Association examines reasons for such readmissions, which is kind of a core predicate…
Read More
Two recent evaluations have examined the effects of using "medical homes" on various outcomes. Today we look at how the CMS version is faring.
Read More
The Government Accounting Office examines what causes variation in the pricing of certain high-cost procedures, finding it is largely attributable to hospital costs.
Read More
A Congressional Budget Office report examines the effects of competition among Part D plans in Medicare's prescription drug benefit.
Read More
A brief from the Centers for Disease Control examines reasons that adults may not have used medications as prescribed, which largely relate to costs.
Read More
The Health Care Cost Institute takes its own look at consumer cost-sharing and price variation.
Read More
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.